Rimtuzalcap
CAS No. 2167246-24-2
Rimtuzalcap ( CAD-1883 )
产品货号. M28737 CAS No. 2167246-24-2
Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥673 | 有现货 |
|
| 10MG | ¥1064 | 有现货 |
|
| 25MG | ¥2111 | 有现货 |
|
| 50MG | ¥3134 | 有现货 |
|
| 100MG | ¥4248 | 有现货 |
|
| 200MG | ¥5733 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥567 | 有现货 |
|
生物学信息
-
产品名称Rimtuzalcap
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。
-
产品描述Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA).(In Vitro):Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.(In Vivo):Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
-
体外实验Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.
-
体内实验Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
-
同义词CAD-1883
-
通路Cell Cycle/DNA Damage
-
靶点Potassium Channel
-
受体human glucagon receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number2167246-24-2
-
分子量378.428
-
分子式C18H24F2N6O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (660.64 mM)
-
SMILESCc1ccn(n1)-c1nc(NC2CCC(F)(F)CC2)cc(n1)N1CCOCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.M A Cascieri, et al. Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor. J Biol Chem. 1999 Mar 26;274(13):8694-7.
产品手册
关联产品
-
Linopirdine
Linopirdine (DUP-996;Linopirine) 是一种有效的 Kv7 (KCNQ) 电压门控钾通道阻滞剂;阻断 KV7.1+7.3 (KCNQ2+3)/M 电流 (IC50=4-7 uM) 和 KV7.1 (KCNQ1) 同聚通道 (IC50=8.9 uM)。
-
Tolazamide
Tolazamide 是一种口服降血糖药,用于 2 型糖尿病患者。
-
PAP-1
PAP-1 是一种选择性、口服活性的 Kv1.3 阻滞剂 (EC50: 2 nM)。
021-51111890
购物车()
sales@molnova.cn

